Sezzle Inc vs 10X Genomics Inc — how do they compare? Sezzle Inc trades at $178.82 (market cap $5.78B), while 10X Genomics Inc trades at $46.82 (market cap $5.48B). The key difference: Sezzle Inc and 10X Genomics Inc are close in size by market cap, and 10X Genomics Inc is trading nearer its 52-week high, Sezzle Inc nearer its low. Which is the better fit depends on your goals.
| SEZL | TXG | |
|---|---|---|
Market Cap | $5.78B | $5.48B |
Sector | Technology | Health |
52-Week High | $188.55 | $45.80 |
52-Week Low | $50.97 | $11.34 |
Enterprise Value | $5.80B | $5.02B |
Signals from Pluang's Aura AI — not financial advice
Sezzle (SEZL) trades at $171.76, down 1.67% today but maintaining strong momentum with consistent earnings beats and bullish technical indicators. The stock shows robust fundamentals with 30.83% net income margin and 91.95% ROE, though valuations remain elevated at P/E 41.72. Recent news highlights product expansion and strong Q1 2026 results, with the company scheduled to report Q2 earnings on August 6, 2026.
Outlook remains positive given earnings momentum and analyst consensus, but high valuation multiples and competitive fintech landscape pose risks. The stock trades above the $162 consensus target, suggesting near-term consolidation potential before potential upward revisions post-earnings.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Sezzle Inc is a financial technology company that operates a Buy Now, Pay Later (BNPL) payment platform. The company allows consumers to make purchases and split the total cost into four interest-free payments over six weeks, primarily serving the e-commerce retail market. Sezzle focuses on promoting financial empowerment by offering a transparent and responsible payment solution to customers at the point of sale.
Read more on SEZL →10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →